ESO SPCC Task force - Improving Efficiency in Cancer Care
18.11.2019
Villa Veronesi, Inveruno, Italy
$destipo0$
Description
This initial meeting is made possible thanks to an unrestricted educational grant received from Bristol-Myers Squibb. Bristol- Myers Squibb exercised no, and had no right to exercise any, control over the programme, its content or speakers. The programme is now shared among all SPCC supporting companies for their participation.
The companies providing financial support to the initiative will be represented at the meeting with the status of observers.
Faculty
Task-Force Invited Members
Matti S. Aapro, Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, Switzerland
Alain Astier, European Society of Oncology Pharmacy, Henri Mondor Univ. Hospital, Paris, France
Andreas Charalambous, EONS, Limassol, Cyprus
Stefan Gijssels, WECAN & Digestive Cancers Europe, Brussels, Belgium
Bengt Jonsson, Karolinska Institute, Stockholm, Sweden
Claudio Lombardo, OECI, Brussels, Belgium
Patrick Miqueu, OECI, Institute Jules Bordet, Brussels, Belgium
Pietro Presti, ECPC and SPCC Torino, Italy
Florian Scotté, Hospital Foch, Suresnes, France
Rosanna Tarricone, Bocconi University, Milan, Italy
Harald Titzer, EONS, Vienna, Austria (connected via Skype)
Cancer World Journalist
Cristina Ferrario, Milan, Italy
Observers
Titta Rosvall-Puplett, Global Policy, Advocacy and Government Affairs, Bristol-Myers Squibb
Hok Pang, Medical Affairs, Bristol-Myers Squibb
Programme
18 November |
||
| 9:00 | Introduction Matti Aapro - Pietro Presti - Florian Scotte |
|
| 9:15 | Why is SPCC presenting this topic? Matti Aapro |
|
| 9:35 | Initial discussion | |
| 10:00 | Example: how PROCHE could be an example Florian Scotte |
|
| 10:20 | Discussion: other examples | |
| 11:10 | How does the proposed programme fit into EONS Educational Framework Andreas Charalambous |
|
| 11:35 | How OECI centres and their patient-partners may contribute to the proposed programme Patrick Miqueu |
|
| 12:00 | Efficiency and productivity of cancer care in Europe Bengt Jönsson |
|
| 12:25 | Making patient organisations part of the treatment pathway Stefan Gijssels |
|
| 12:50 | The role of pharmacists to improve patient care Alain Astier |
|
| 13:15 | General discussion of the data | |
| 13:40 | Lunch | |
| 14:30 | Next steps Matti Aapro |
|
| 15:10 | Structuring a position paper | |
| 15:40 | Final discussion | |